{"id":"W4242460399","doi":"10.1200/jco.2017.74.6065","title":"Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":650,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Association for Molecular Pathology; American Society of Clinical Oncology; American Association for Cancer Research","keywords":"Medicine; Atezolizumab; Nivolumab; Pembrolizumab; Oncology; Internal medicine; Lung cancer; Guideline; Docetaxel; Pemetrexed; Chemotherapy; Clinical trial; Cancer; Intensive care medicine; Immunotherapy; Pathology; Cisplatin","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009930776,0.001313998,0.002677516,0.004833305,0.001070477,0.002831473,0.003802397,0.004970651,0.007580738],"category_scores_gemma":[0.03881859,0.0007718513,0.004971622,0.005701507,0.0007839918,0.002952634,0.002253084,0.005925884,0.005673259],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004477402,"about_ca_system_score_gemma":0.01748816,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01878451,"about_ca_topic_score_gemma":0.04192238,"domain_scores_codex":[0.9897132,0.003230978,0.00326926,0.0004721726,0.002945485,0.0003689056],"domain_scores_gemma":[0.9677725,0.007257355,0.004785026,0.0006382724,0.01832707,0.001219811],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005864748,0.0001082586,0.0009719022,0.01854705,0.0003562552,0.000171712,0.0002496387,0.0006607731,0.0002849818,0.00245282,0.6741895,0.3019485],"study_design_scores_gemma":[0.0003037614,0.00008828654,0.002600786,0.07748397,0.00101927,0.0005920586,0.0001838627,0.0006344893,0.0002276938,0.005639348,0.911147,0.00007933828],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.002931103,0.582189,0.02023881,0.2803135,0.01944305,0.00799136,0.016774,0.000964577,0.06915472],"genre_scores_gemma":[0.01306973,0.6912302,0.1267491,0.1048733,0.007396676,0.01084642,0.02772488,0.0003881252,0.01772156],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.01878451,"threshold_uncertainty_score":0.05251956,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1717391177742632,"score_gpt":0.6087778275094344,"score_spread":0.4370387097351712,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}